Cargando…

Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells

Detalles Bibliográficos
Autores principales: Wang, Xu, Hui, Renjie, Chen, Yun, Wang, Wentao, Chen, Yujiao, Gong, Xiaohai, Jin, Jian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768923/
https://www.ncbi.nlm.nih.gov/pubmed/33381044
http://dx.doi.org/10.3389/fphar.2020.603491
_version_ 1783629233545805824
author Wang, Xu
Hui, Renjie
Chen, Yun
Wang, Wentao
Chen, Yujiao
Gong, Xiaohai
Jin, Jian
author_facet Wang, Xu
Hui, Renjie
Chen, Yun
Wang, Wentao
Chen, Yujiao
Gong, Xiaohai
Jin, Jian
author_sort Wang, Xu
collection PubMed
description
format Online
Article
Text
id pubmed-7768923
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-77689232020-12-29 Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells Wang, Xu Hui, Renjie Chen, Yun Wang, Wentao Chen, Yujiao Gong, Xiaohai Jin, Jian Front Pharmacol Pharmacology Frontiers Media S.A. 2020-11-26 /pmc/articles/PMC7768923/ /pubmed/33381044 http://dx.doi.org/10.3389/fphar.2020.603491 Text en Copyright © 2020 Wang, Hui, Chen, Wang, Chen, Gong and Jin http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Pharmacology
Wang, Xu
Hui, Renjie
Chen, Yun
Wang, Wentao
Chen, Yujiao
Gong, Xiaohai
Jin, Jian
Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
title Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
title_full Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
title_fullStr Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
title_full_unstemmed Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
title_short Corrigendum: Discovery of Novel Doxorubicin Metabolites in MCF7 Doxorubicin-Resistant Cells
title_sort corrigendum: discovery of novel doxorubicin metabolites in mcf7 doxorubicin-resistant cells
topic Pharmacology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7768923/
https://www.ncbi.nlm.nih.gov/pubmed/33381044
http://dx.doi.org/10.3389/fphar.2020.603491
work_keys_str_mv AT wangxu corrigendumdiscoveryofnoveldoxorubicinmetabolitesinmcf7doxorubicinresistantcells
AT huirenjie corrigendumdiscoveryofnoveldoxorubicinmetabolitesinmcf7doxorubicinresistantcells
AT chenyun corrigendumdiscoveryofnoveldoxorubicinmetabolitesinmcf7doxorubicinresistantcells
AT wangwentao corrigendumdiscoveryofnoveldoxorubicinmetabolitesinmcf7doxorubicinresistantcells
AT chenyujiao corrigendumdiscoveryofnoveldoxorubicinmetabolitesinmcf7doxorubicinresistantcells
AT gongxiaohai corrigendumdiscoveryofnoveldoxorubicinmetabolitesinmcf7doxorubicinresistantcells
AT jinjian corrigendumdiscoveryofnoveldoxorubicinmetabolitesinmcf7doxorubicinresistantcells